• Trump's FDA is making news for wrong reasons The Philadelphia Tribune Tue, 18 Nov 2025 05:00:00 GMT
• Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA Yahoo Finance Mon, 17 Nov 2025 17:15:44 GMT
• risk adjusted return profile for uniqure n.v. analyzed - july 2025 sector moves & stepwise trade execution plans newser.com Sun, 16 Nov 2025 03:29:02 GMT
• uniqure n.v. investigation alert: kessler topaz meltzer & check, llp encourages uniqure n.v. (nasdaq: qure) investors with signifi... Markets Financial Content Sat, 15 Nov 2025 16:45:00 GMT
• uniqure nv hits day high with 15.18% surge amid market volatility Markets Mojo Sat, 15 Nov 2025 16:23:05 GMT
• uniQure N.V. (NASDAQ:QURE) Analysts Just Slashed Next Year's Revenue Estimates By 26% Yahoo Finance Sat, 15 Nov 2025 12:07:35 GMT
• uniqure stock hits 5-year high as analysts hail huntington’s therapy data — retail spots ‘diamond in rough of biotech’ MSN Sat, 15 Nov 2025 03:36:57 GMT
• volatility clustering patterns for uniqure n.v. - earnings overview report & long-term growth portfolio plans newser.com Fri, 14 Nov 2025 19:59:19 GMT
• how institutional buying supports uniqure n.v. stock - 2025 trading volume trends & real-time market sentiment alerts newser.com Fri, 14 Nov 2025 16:54:28 GMT
• what catalysts could drive uniqure n.v. stock higher - july 2025 institutional & scalable portfolio growth methods newser.com Fri, 14 Nov 2025 16:39:04 GMT
• why uniqure n.v. stock is rated strong buy - weekly gains report & verified entry point detection Fundação Cultural do Pará Fri, 14 Nov 2025 11:53:48 GMT
• predicting uniqure n.v. trend using moving averages - market volume report & advanced swing trade entry plans newser.com Fri, 14 Nov 2025 11:13:01 GMT
• uniqure n.v. investigated for securities fraud violations - contact the djs law group to discuss your rights - qure MarketScreener Fri, 14 Nov 2025 09:18:07 GMT
• uniqure nv hits day high with 15.18% surge amid market volatility Markets Mojo Thu, 13 Nov 2025 21:06:18 GMT
• Makary, Prasad outline pathway for bespoke gene therapy statnews.com Thu, 13 Nov 2025 14:40:11 GMT
• uniqure’s ceo dined with investors. here’s what he said statnews.com Thu, 13 Nov 2025 11:32:24 GMT
• Analysts Have Lowered Expectations For uniQure N.V. (NASDAQ:QURE) After Its Latest Results Yahoo Finance Thu, 13 Nov 2025 10:30:18 GMT
• A Deep Dive into uniQure (QURE) Valuation After FDA Uncertainty Shakes Huntington’s Disease Program simplywall.st Wed, 12 Nov 2025 21:35:59 GMT
• nasdaq: qure investigation reminder: kessler topaz meltzer & check, llp encourages uniqure n.v. (nasdaq: qure) investors with sign... Markets Financial Content Wed, 12 Nov 2025 20:54:00 GMT
• uniqure (qure): wells fargo adjusts price target to $60, maintai GuruFocus Wed, 12 Nov 2025 16:05:44 GMT
• QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm GlobeNewswire Wed, 12 Nov 2025 15:00:00 GMT
• positive long-term outlook for uniqure amid strong data and strategic advancements TipRanks Wed, 12 Nov 2025 14:57:42 GMT
• h.c. wainwright maintains uniqure nv(qure.us) with buy rating, maintains target price $70 富途牛牛 Wed, 12 Nov 2025 14:31:00 GMT
• wells fargo maintains uniqure nv(qure.us) with buy rating, cuts target price to $60 富途牛牛 Wed, 12 Nov 2025 12:33:00 GMT
• uniqure nv hits day high with 17.93% surge amid strong intraday performance Markets Mojo Wed, 12 Nov 2025 12:24:52 GMT
• uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences Yahoo Finance Wed, 12 Nov 2025 12:00:00 GMT
• uniqure n.v. investigation: investors encouraged to contact kirby mcinerney llp The AI Journal Wed, 12 Nov 2025 01:27:22 GMT
• uniQure (QURE) Is Down 14.1% After FDA Alters AMT-130 Approval Pathway - Has The Bull Case Changed? simplywall.st Tue, 11 Nov 2025 15:25:05 GMT
• Chardan Capital Maintains uniQure N.V. (QURE) Buy Recommendation Nasdaq Tue, 11 Nov 2025 14:41:00 GMT
• uniqure n.v. (nasdaq:qure) q3 2025 earnings call transcript Insider Monkey Tue, 11 Nov 2025 13:49:30 GMT
• chardan capital maintains 'buy' rating on qure with $53 price ta GuruFocus Tue, 11 Nov 2025 13:42:22 GMT
• william blair reiterates market perform rating on uniqure stock amid amt-130 uncertainty Investing.com Nigeria Tue, 11 Nov 2025 12:56:53 GMT
• Leerink Partners Maintains uniQure N.V. (QURE) Outperform Recommendation Nasdaq Tue, 11 Nov 2025 12:03:00 GMT
• UniQure outlines urgent FDA engagement for AMT-130 as BLA timing turns uncertain MSN Tue, 11 Nov 2025 10:19:08 GMT
• qure investors have opportunity to join uniqure n.v. fraud investigation with the schall law firm PR Newswire Tue, 11 Nov 2025 09:40:00 GMT
• uniqure n.v. investigated for securities fraud violations - contact the djs law group to discuss your rights - qure MarketScreener Tue, 11 Nov 2025 09:24:08 GMT
• qure investigation reminder: kessler topaz meltzer & check, llp encourages uniqure n.v. (nasdaq: qure) investors with significant ... PR Newswire Tue, 11 Nov 2025 01:30:00 GMT
• stifel lowers uniqure stock price target to $50 from $65 on fda feedback by investing.com Investing.com South Africa Tue, 11 Nov 2025 01:17:26 GMT
• uniqure nv earnings missed by $0.47, revenue fell short of estimates Investing.com South Africa Tue, 11 Nov 2025 00:36:53 GMT
• uniqure n.v. earnings call: pipeline progress amid challenges TipRanks Tue, 11 Nov 2025 00:21:31 GMT
• qure: leerink partners lowers price target, maintains outperform rating | qure stock news GuruFocus Mon, 10 Nov 2025 21:37:04 GMT
• uniqure’s amt-130: a promising breakthrough in huntington’s disease treatment amidst regulatory challenges TipRanks Mon, 10 Nov 2025 21:11:15 GMT
• uniQure NV (QURE) Q3 2025 Earnings Call Highlights: Promising Data Amid Regulatory Challenges Yahoo Finance Mon, 10 Nov 2025 21:01:10 GMT
• Stifel lowers uniQure stock price target to $50 from $65 on FDA feedback Investing.com Mon, 10 Nov 2025 20:53:19 GMT
• uniqure stock price target lowered to $60 by leerink on regulatory uncertainty Investing.com Nigeria Mon, 10 Nov 2025 20:20:08 GMT
• uniqure’s amt-130: promising results amid regulatory challenges support buy rating TipRanks Mon, 10 Nov 2025 19:56:48 GMT
• uniqure (qure) faces uncertainty in bla submission despite positive amt-130 data GuruFocus Mon, 10 Nov 2025 18:05:46 GMT
• From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside (NASDAQ:QURE) Seeking Alpha Mon, 10 Nov 2025 17:44:37 GMT
• uniqure (qure) reveals promising data amid regulatory challenges GuruFocus Mon, 10 Nov 2025 16:31:55 GMT
• uniqure’s regulatory challenges and mixed signals lead to hold rating TipRanks Mon, 10 Nov 2025 16:30:44 GMT
• uniQure (QURE) Is Down 19.0% After FDA Questions Data for AMT-130 Gene Therapy Approval Pathway – Has The Bull Case Changed? Yahoo Finance Mon, 10 Nov 2025 14:12:46 GMT
• uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates Yahoo Finance Mon, 10 Nov 2025 13:15:04 GMT
• uniqure (qure) q3 earnings miss expectations, revenue up 61.6% y GuruFocus Mon, 10 Nov 2025 13:12:24 GMT
• uniqure nv earnings missed by $0.47, revenue fell short of estimates Investing.com Mon, 10 Nov 2025 12:44:51 GMT
• earnings flash (qure) uniqure posts q3 net loss $1.38 a share, vs. factset est of $0.90 loss MarketScreener Mon, 10 Nov 2025 12:38:59 GMT
• uniqure misses estimates but finds support and fresh funding Finimize Mon, 10 Nov 2025 12:28:35 GMT
• earnings flash (qure) uniqure n.v. reports q3 revenue $3.7m, vs. factset est of $5.8m MarketScreener Mon, 10 Nov 2025 12:16:21 GMT
• uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire Mon, 10 Nov 2025 12:05:00 GMT
• uniqure (nasdaq: qure) highlights amt-130 75% slowing at 36 months; fda follow-up set Stock Titan Mon, 10 Nov 2025 12:05:00 GMT
• uniqure stock hits 18-month high after fda agreement clears pathway for huntington’s treatment: retail gets more optimistic MSN Mon, 10 Nov 2025 11:21:38 GMT
• can uniqure n.v. (uq1) stock sustain revenue momentum - gap up & reliable entry point trade alerts newser.com Mon, 10 Nov 2025 07:30:20 GMT
• can uniqure n.v. (uq1) stock sustain revenue momentum - july 2025 price swings & accurate buy signal alerts newser.com Sun, 09 Nov 2025 09:09:18 GMT
• is uniqure n.v. stock trading at a premium valuation - market performance summary & low risk investment opportunities newser.com Sun, 09 Nov 2025 09:00:24 GMT
• nasdaq: qure investigation: kessler topaz meltzer & check, llp encourages uniqure n.v. (nasdaq: qure) investors with significant l... NewMediaWire Sat, 08 Nov 2025 17:33:30 GMT
• nasdaq: qure investigation reminder: kessler topaz meltzer GlobeNewswire Fri, 07 Nov 2025 19:34:40 GMT
• uniqure nv expected to post a loss of 90 cents a share - earnings preview TradingView Fri, 07 Nov 2025 15:28:20 GMT
• uniQure Staggers at FDA, Recursion’s Microglia Map, Leadership Transitions Genetic Engineering and Biotechnology News Fri, 07 Nov 2025 12:37:26 GMT
• fda faces scrutiny as biohaven, uniqure, and sarepta therapeutics encounter drug development delays geneonline.com Fri, 07 Nov 2025 06:37:43 GMT
• uniqure’s fda nightmare: how a single therapy sparked a $300m meltdown! Smartkarma Thu, 06 Nov 2025 23:42:06 GMT
• uniqure (nasdaq: qure) to host earnings call nov. 10 at 8:30 a.m. et, before market open Stock Titan Thu, 06 Nov 2025 12:05:00 GMT
• what catalysts could drive uniqure n.v. stock higher - portfolio risk report & intraday high probability alerts newser.com Thu, 06 Nov 2025 09:15:09 GMT
• uniQure to Announce Third Quarter 2025 Financial Results Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• predicting uniqure n.v. trend using moving averages - quarterly profit review & consistent income trade ideas newser.com Thu, 06 Nov 2025 07:57:37 GMT
• can uniqure n.v. stock hit record highs again - july 2025 institutional & fast entry and exit trade plans newser.com Thu, 06 Nov 2025 07:32:15 GMT
• how institutional buying supports uniqure n.v. stock - market activity recap & entry point confirmation signals newser.com Thu, 06 Nov 2025 05:56:48 GMT
• can uniqure n.v. stock hit analyst price targets - 2025 biggest moves & verified entry point detection newser.com Thu, 06 Nov 2025 05:14:23 GMT
• can uniqure n.v. (uq1) stock sustain revenue momentum - swing trade & real-time market sentiment reports newser.com Thu, 06 Nov 2025 04:06:16 GMT
• has uniqure’s volatile 63% drop created a compelling opportunity after pipeline news? simplywall.st Thu, 06 Nov 2025 03:54:31 GMT
• uniqure n.v. stock outlook for year - market risk summary & long-term capital growth ideas newser.com Wed, 05 Nov 2025 23:43:32 GMT
• the shocking plot twist that sent this biotech crashing Investor's Business Daily Wed, 05 Nov 2025 21:28:00 GMT
• uniqure says fda no longer agrees amt-130 data ‘adequate’ to support bla MSN Wed, 05 Nov 2025 21:06:33 GMT
• biohaven stock hits 52-week low, cuts r&d spending after fda rejection Benzinga Wed, 05 Nov 2025 17:53:02 GMT
• uniqure (nasdaq:qure) trading down 14.7% following analyst downgrade MarketBeat Wed, 05 Nov 2025 15:58:14 GMT
• risk adjusted return profile for uniqure n.v. analyzed - quarterly market review & weekly return optimization plans newser.com Wed, 05 Nov 2025 11:45:01 GMT
• can uniqure n.v. stock hit analyst price targets - earnings summary report & weekly high potential alerts newser.com Wed, 05 Nov 2025 09:48:51 GMT
• what data driven models say about uniqure n.v.’s future - 2025 trading recap & verified swing trading watchlists newser.com Wed, 05 Nov 2025 09:05:28 GMT
• y intercept hong kong ltd purchases new stake in uniqure n.v. $qure MarketBeat Wed, 05 Nov 2025 08:36:36 GMT
• uniqure stock price target lowered to $45 at rbc capital on fda setback Investing.com Philippines Wed, 05 Nov 2025 08:22:56 GMT
• Pfizer and Novo Battle Over Metsera, Tidmarsh Fights FDA Exit, UniQure and Sarepta Face Setbacks BioSpace Wed, 05 Nov 2025 08:00:00 GMT
• UNIQURE ALERT: Bragar Eagel & Squire, P.C. is Investigating GlobeNewswire Wed, 05 Nov 2025 08:00:00 GMT
• qure investors have opportunity to join uniqure n.v. fraud investigation with the schall law firm GlobeNewswire Wed, 05 Nov 2025 08:00:00 GMT
• uniqure n.v. (nasdaq:qure) given average rating of "moderate buy" by analysts MarketBeat Wed, 05 Nov 2025 06:27:57 GMT
• uniqure n.v. stock outlook for year - swing trade & fast momentum stock entry tips newser.com Wed, 05 Nov 2025 05:31:49 GMT
• uniqure (qure): examining valuation following recent share price volatility simplywall.st Wed, 05 Nov 2025 00:55:11 GMT
• goldman sachs maintains uniqure n.v. (qure) neutral recommendation Nasdaq Wed, 05 Nov 2025 00:06:00 GMT
• rbc capital maintains uniqure n.v. (qure) outperform recommendation Nasdaq Wed, 05 Nov 2025 00:06:00 GMT
• traders purchase large volume of uniqure call options (nasdaq:qure) MarketBeat Tue, 04 Nov 2025 23:00:48 GMT
• uniQure N.V. INVESTIGATION: Kirby McInerney LLP Announces GlobeNewswire Tue, 04 Nov 2025 23:00:00 GMT
• UniQure Is Latest Gene Therapy Sponsor Surprised By US FDA Reversal Citeline News & Insights Tue, 04 Nov 2025 22:26:42 GMT
• chardan capital has lowered expectations for uniqure (nasdaq:qure) stock price MarketBeat Tue, 04 Nov 2025 22:20:57 GMT
• FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy Sahm Tue, 04 Nov 2025 19:30:00 GMT
• uniqure (qure) sees analyst price target lowered by rbc capital GuruFocus Tue, 04 Nov 2025 17:37:14 GMT
• uniqure (qure) analyst rating update: goldman sachs lowers price target | qure stock news GuruFocus Tue, 04 Nov 2025 17:37:14 GMT
• goldman sachs maintains uniqure nv(qure.us) with hold rating, cuts target price to $38 富途牛牛 Tue, 04 Nov 2025 17:32:04 GMT
• uniqure price target lowered to $38 from $56 at goldman sachs TipRanks Tue, 04 Nov 2025 14:57:27 GMT
• chardan cuts price target on uniqure to $53 from $76, keeps buy rating MarketScreener Tue, 04 Nov 2025 13:46:06 GMT
• rbc cuts price target on uniqure to $45 from $65, keeps outperform, speculative risk MarketScreener Tue, 04 Nov 2025 13:31:37 GMT
• william blair downgrades uniqure n.v to market perform from outperform MarketScreener Tue, 04 Nov 2025 13:24:07 GMT
• uniqure (qure) downgraded by william blair to market perform | q GuruFocus Tue, 04 Nov 2025 12:57:18 GMT
• uniqure (qure) price target lowered by hc wainwright & co. | qur GuruFocus Tue, 04 Nov 2025 12:08:47 GMT
• hc wainwright & co. maintains uniqure n.v. (qure) buy recommendation Nasdaq Tue, 04 Nov 2025 12:02:00 GMT
• uniqure (qure) downgraded by william blair amid uncertainty over amt-130 GuruFocus Tue, 04 Nov 2025 11:58:40 GMT
• uniqure stock plunges 50% on fda shocker – what’s next for qure’s gene therapy ambitions? ts2.tech Tue, 04 Nov 2025 11:55:50 GMT
• chardan capital maintains uniqure n.v. (qure) buy recommendation Nasdaq Tue, 04 Nov 2025 11:37:00 GMT
• uniqure price target lowered to $70 from $110 at h.c. wainwright TipRanks Tue, 04 Nov 2025 11:35:19 GMT
• can uniqure n.v. (uq1) stock sustain revenue momentum - 2025 technical patterns & low drawdown investment ideas newser.com Tue, 04 Nov 2025 11:34:32 GMT
• h.c. wainwright maintains uniqure nv(qure.us) with buy rating, cuts target price to $70 富途牛牛 Tue, 04 Nov 2025 11:32:00 GMT
• fda rejects uniqure’s huntington’s disease gene therapy over external control data concerns geneonline.com Tue, 04 Nov 2025 09:53:55 GMT
• FDA halts uniQure’s plans for Huntington’s disease gene therapy Pharmaceutical Technology Tue, 04 Nov 2025 08:00:00 GMT
• A Closer Look at uniQure (QURE) Valuation Following FDA Shift on Huntington’s Gene Therapy Data Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
• Is Now the Moment to Reassess uniQure After Its 516% Surge and Sharp Drop? Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
• UniQure: Controversy Abounds As Stock Price Halves On FDA News (NASDAQ:QURE) Seeking Alpha Tue, 04 Nov 2025 08:00:00 GMT
• uniqure stock price target lowered to $45 at rbc capital on fda setback Investing.com Tue, 04 Nov 2025 08:00:00 GMT
• uniqure’s plan for amt-130 approval hits snag at fda huntingtonsdiseasenews.com Tue, 04 Nov 2025 08:00:00 GMT
• nasdaq: qure investigation alert: kessler topaz meltzer & check, llp encourages uniqure n.v. (nasdaq: qure) investors with signifi... Business Wire Tue, 04 Nov 2025 08:00:00 GMT
• uniqure stock price target lowered to $70 at h.c. wainwright on fda setback Investing.com Tue, 04 Nov 2025 08:00:00 GMT
• can uniqure n.v. stock hit analyst price targets - market volume summary & community consensus stock picks newser.com Tue, 04 Nov 2025 07:19:33 GMT
• is uniqure n.v. stock a bargain at current levels - july 2025 wrapup & precise entry and exit recommendations newser.com Tue, 04 Nov 2025 03:14:01 GMT
• PreBLA Meeting With FDA Sinks uniQure’s Hopes for Approval of Huntington Disease Gene Therapy AMT-130 Based Primarily on Phase 1/2... CGTLive® Tue, 04 Nov 2025 01:13:38 GMT
uniQure N.V(NASDAQ:QURE) 
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also e...
Website: http://www.uniqure.com
Founded: 1998
Full Time Employees: 248
Sector: Healthcare
Industry: Biotechnology